Figure 1.
Changes in hemoglobin and IgA levels. BDR: bortezomib, dexamethasone, and rituximab combination therapy. CAD: cold agglutinin disease.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.